Publicly reported buying by China’s central bank has been so low this year — 1.9 tonnes purchased in August, 1.9 tonnes in July and 2.2 tonnes in June — that few in the market believe the official ... ( read original story ...)
China’s Maxone steps into the global probe-card elite with IPO approval, Huawei support
Maxone Semiconductor (Suzhou) has cleared the Shanghai STAR Market IPO review, a notable milestone in China's effort to end foreign control of the wafer-test hardware market. It is the only Chinese ... ( read original story ...)
Exclusive: China’s securities regulatory chief seeks approval to step down, sources say
China's securities watchdog chief, Wu Qing, has sought approval to step down, people with knowledge of the matter said, in what would be an abrupt and unexpected exit for a regulatory head brought in ... ( read original story ...)
China’s New Energy Surge Powers Stock Market Uptick
China stocks rose on Thursday, mainly driven by new energy sector gains. The Shanghai Composite and CSI300 indexes experienced recoveries, benefiting from year-end investor shifts. Prominent increases ... ( read original story ...)
Shanghai Kindly Medical Instruments Proposes Full Circulation of H Shares
The latest announcement is out from Shanghai Kindly Medical Instruments Co., Ltd. Class H ( ($HK:1501) ). Shanghai Kindly Medical Instruments Co., ... ( read original story ...)
Overseas investors hold over 3.5 trillion yuan worth of China A-shares: CSRC
China's capital market has continued to expand its high-level institutional opening-up, with the value of A-shares held by overseas investors rising from over 3 trillion yuan ($420 billion) at the end ... ( read original story ...)
Chinese drug developer Biokin postpones Hong Kong listing, citing ‘market conditions’
Decision likely reflects ‘some pullback in risk appetite, with growth-stock share prices coming off their highs’, Morningstar analyst says. ( read original story ...)